32
Participants
Start Date
December 16, 2019
Primary Completion Date
October 13, 2022
Study Completion Date
October 13, 2022
CDP1
"Single dose part:~Cohort 1:400 mg/m2; Cohort 2: 500 mg/m2; Cohort 3: 750 mg/m2;~Multi-dose Part:~Starting dose: Cohort 1:400 mg/m2; Cohort 2/3: 500 mg/m2; Maintenance dose: Cohort 1:250 mg/m2, QW; Cohort 2/3: 500 mg/m2, Q2W;"
CDP1
Starting dose: 400 mg/m2; Maintenance dose: 250 mg/m2,QW;
TIP chemotherapy
Paclitaxel: 175 mg/m2 in day 1, Q3W; Ifosfamide: 1200 mg/m2 in day 1, day 2 and day 3, Q3W; Cisplatin: 25 mg/m2 in day 1, day 2 and day 3, Q3W; Participants received TIP chemotherapy up to 6 cycles (21 days per cycle).
Dragonboat Biopharmaceutical,Co.,Ltd, Shanghai
Lead Sponsor
Dragonboat Biopharmaceutical Company Limited
INDUSTRY